Matches 1 - 50 out of 389 1 2 3 4 5 6 7 8 >
Match Document Document Title
7381719 Diaryl ethers as opioid receptor antagonist  
A compound of the formula (I) wherein the variables X 1 to X 10 , R 1 to R 7 including R 3′ , E, v, y, z, A and B are as described, or a pharmaceutically acceptable salt, solvate, enantiomer,...
7365073 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4  
Disclosed are certain 3-(heteroaryl)alanine derivatives which bind VLA-4 and inhibit leukocyte adhesion mediated by VLA-4. Such compounds are useful in the treatment of inflammatory diseases in a...
7354924 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives  
This invention provides Compounds I having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with azaindoleoxoacetyl...
7319099 Benzoyl-piperazine derivatives  
The invention relates to compounds of formula wherein the substituents are described herein. The compounds may be used in the treatment of illnesses based on the glycine uptake inhibitor, such...
7317013 Cyclic pyrazinoylguanidine sodium channel blockers  
The present invention provides sodium channel blockers represented by formula (I): where the structural variables are defined herein. The compounds of the present invention may be used for...
7307081 Piperidine derivatives useful as CCR5 antagonists  
The present invention provides a compound of the formula or a pharmaceutically acceptable salt or solvate thereof, wherein the various moieties are as defined in the specification. The present...
7300930 Therapeutic acridone and acridine compounds  
The present invention pertains to acridone and acridine compounds of formula (I), wherein either: (a) K is ═O, L is —H, alpha is a single bond, beta is a double bond, gamma is a single bond...
7262197 Phospholipase C inhibitors for use in treating inflammatory disorders  
This invention is directed to heterocyclyl-substituted anilino phospholipase C inhibitor compounds useful in treating or ameliorating an inflammatory disorders and/or restenosis of the general...
7259162 Benzazole derivatives and their use as JNK modulators  
The present invention is related to benzazole derivatives notably for use as pharmaceutically active compounds, as well as to pharmaceutical formulations containing such benzazole derivatives. Said...
7253168 Substituted 1-benzyl-4-substituted piperazine analogues  
Compounds of Formula I are provided, in which variables are as described herein: Such compounds may be used to modulate MCH binding to MCH receptors in vivo or in vitro, and are particularly...
7244722 Amino-substituted 1H-pyrazin-2-ones and 1H-quinoxalin-2-ones  
Compounds of the general formula (I): wherein m, n, R 1 , R 2 , R 3 and R 4 are as described in the specification. Further included are pharmaceutical compositions comprising the...
7238693 Aryl carbamate derivatives, preparation and use thereof  
The present invention relates to novel compounds, the preparation and use, particularly therapeutic, thereof. More specifically, it relates to compounds derived from aryl carbamates, the...
7238688 Piperidine compounds  
Disclosed are novel compounds of the formula Also disclosed are pharmaceutical compositions comprising the compounds of Formula I. Also disclosed are methods of treating various diseases or...
7226925 Compounds, their use and preparation  
The invention relates to compounds of the general Formula (I): The compounds may be prepared by per se conventional methods and can be used for treating a human or animal subject suffering from...
7196080 Phenylpyridinecarbonylpiperazinederivative  
The present invention relates to a compound which is represented by the following general formula and has type 4 phosphodiesterase inhibitory action, and uses and an intermediate compound thereof. ...
7189715 Compositions comprising zopiclone derivatives and methods of making and using the same  
The invention is directed to racemic and stereomerically pure compounds of Formula 3: and to pharmaceutical compositions comprising them, methods of their use, and methods of their preparation.
7186715 Piperazine- and piperidine-derivatives as melanocortin receptor agonists  
The present invention relates to melanocortin receptor agonists of formula I, which is useful in the treatment of obesity, diabetes and male and/or female sexual dysfunction
7179807 5-substituted-2-arylpyrazines  
Novel 5-substituted-2-arylpyrazine compounds are provided. Such compounds can act as selective modulators or CRF receptors. Compounds of the invention are provided by the following formula: The...
7160886 Acylated piperazine derivatives as melanocortin-4 receptor agonists  
Certain novel N-acylated piperazine derivatives are agonists of the human melanocortin receptor(s) and, in particular, are selective agonists of the human melanocortin-4 receptor (MC-4R). They are...
7153858 Arylpiperazinyl compounds  
The invention relates to 5-HT receptor agonists or antagonists. Novel arylpiperazinyl sulfonamide compounds represented by Formulae I: and II, and synthesis and uses of those compounds for treating...
7153856 Cyclic protein tyrosine kinase inhibitors  
Novel cyclic compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders...
7122544 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto  
Compounds having activity as inhibitors of IKK are disclosed, particularly IKK-2. The compounds of this invention are anilinopyrimidine derivatives having the following structure: wherein R 1 ...
7119086 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use  
The invention relates to compounds of formula: and also to the salts thereof with mineral or organic acids, and the solvates and/or hydrates thereof, with affinity for and selectivity towards...
7105519 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same  
Inhibitors of MIF are provided which have utility in the treatment of a variety of disorders, including the treatment of pathological conditions associated with MIF activity. The inhibitors of MIF...
7101886 Phenylalkyl and pyridylalkyl piperazine derivatives  
This invention relates to compounds of the formula 1 wherein R 1 , R 3 , R 4 , X 1 , and X 2 are defined as in the specification, pharmaceutical compositions containing them and their use in...
7098213 CCR5 antagonists useful for treating AIDS  
Compounds of the formula or a pharmaceutically acceptable salt or isomer thereof, wherein: Q, X and Z are CH or N; R, R 4 –R 7 and R 13 are H or alkyl; R 1 is H, alkyl, fluoroalkyl,...
7094779 Piperazine oxime dervatives having NK-1 receptor antagonistic activity  
The present invention relates to a group of novel piperazine oxime derivatives having interesting NK-1 antagonistic activity. The invention relates to compounds of the general formula (1) wherein:...
7084141 Inhibitors of macrophase migration inhibitory factor and methods for identifying the same  
Inhibitors of MIF are provided which have utility in the treatment of a variety of disorders, including the treatment of pathological conditions associated with MIF activity. The inhibitors of MIF...
7071180 Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases  
The invention relates to compounds of the general formula (I): wherein Ar is optionally substituted aryl or heteroaryl; A is (i) —O—, —S—, —SO 2 —, —NH—, (ii) a C 1-4...
7030110 Cyclic oxyguanidine pyrazinones as protease inhibitors  
Cyclic oxyguanidine pyrazinone compounds are described, including compounds of the Formula I: wherein R 3 , R 4 , R 5 , W, and A are as set forth in the specification, as well as hydrates,...
7026314 Therapeutic chromone compounds  
Provided herein is a compound of the formula (I) wherein said compound is useful for the treatment of psychiatric disorders including but not limited to depression, generalized anxiety, eating,...
7015216 Heteroaryl-β-alanine derivatives as alpha 4 integrin inhibitors  
Disclosed are a series of heteroaryl-β-alanine derivatives, compositions containing them, processes for their preparation and their use in medicine.
7008946 CCR5 antagonists useful for treating AIDS  
Compounds of the formula or a pharmaceutically acceptable salt or isomer thereof, wherein: Q, X and Z are CH or N; R, R 4 –R 7 and R 13 are H or alkyl; R 1 is H, alkyl, fluoroalkyl,...
6960580 Nitrogenous heterocyclic substituted quinoline compounds  
The present invention relates to nitrogen-containing heterocyclic quinoline compounds and pharmaceutically acceptable salts thereof which have inhibitory activity on the phosphorylation of kinases,...
6958331 Bradykinin receptor antagonists  
The invention relates to sulfonyl amine derivatives of formula IA wherein R 5A , X 1 , X 2 , R 9 and R 10 are as defined herein, which derivatives are useful as bradykinin B 1 receptor...
6949552 Remedial agent for anxiety neurosis or depression and piperazine derivative  
There are provided a therapeutic preparation for anxiety neurosis or depression which comprises a MC 4 receptor antagonist as an effective ingredient; and a piperazine derivative represented by...
6939884 Pharmaceutical agents containing acyclovir, fusaric acid and derivatives thereof  
Compositions are provided, which comprise at least one nucleoside analogue inhibitor, pharmaceutically acceptable salts, solvates, or prodrugs thereof and fusaric acid, derivatives, or...
6916804 Pyrimidine A2b selective antagonist compounds, their synthesis and use  
The subject invention provides compounds having the structure: wherein R 1 is substituted or unsubstituted phenyl or a 5-6 membered heterocyclic or heteroaromatic ring containing from 1 to 5...
6861432 Piperazine derivatives that destabilize androgen receptors  
This invention relates to new piperazine derivatives of general formula I, in which V, W, n, R, R′, i, j, Y and Z have the meaning that is indicated in the description. The compounds...
6838461 N-(indolcarbonyl-)piperazine derivatives  
Compounds of the formula I in which R 1 , R 2 , R 4 and R 5 have the meanings indicated in claim 1 , are potent 5-HT 2A antagonists and are suitable for the treatment of psychoses,...
6833369 Angiogenesis inhibiting 5-substituted-1,2,4,-thiadiazolyl derivatives  
This invention concerns compounds of formula the N-oxide forms, the pharmaceutically acceptable acid addition salts and stereochemically isomeric forms thereof, wherein X is CH or N; R 1 is...
6797709 Aromatic nitrogen-containing 6-membered cyclic compounds  
An aromatic nitrogen-containing 6-membered cyclic compound of the formula (I): wherein Ring A is a substituted or unsubstituted nitrogen-containing heterocyclic group; R 1 is a substituted or...
6787546 Heterocycle derivatives and drugs  
The object of the invention is to provide an excellent compound as a drug. The invention relates to a heterocyclic compound shown by the following formula: A—B—D—E [ 1] wherein A is...
6780863 Bis-basic compounds with tryptase-inhibitory activity  
Compounds of which the following are exemplary: These have tryptase-inhibiting activity and are useful for the treatment of inflammatory and allergic disease conditions.
6747030 Piperazine derivatives as 5-HT1B antagonists  
Piperazine derivatives of formula(1), processes for their preparation, pharmaceutical compositions containing them in the treatment of CNS and other disorders and in their use in therapy as 5-HT...
6740661 Farnesyl protein transferase inhibitors  
Disclosed are compounds of the formula: wherein R 13 represents an imidazole ring; R 14 represents a carbamate, urea, amide or sulfonamide group; R 8 represents H when the alkyl chain between...
6734183 Compounds  
Compounds of the formula I useful as metalloproteinase inhibitors, especially as inhibitors of MMP 13.
6727253 Treatment of accidental extravasation of anthracyclines  
The present invention relates to a method for pharmacological treatment of accidental extravasation of topoisomerase II poisons, such as anthracyclines. In particular, the invention relates to the...
6716871 Cyclic AMP-specific phosphodie sterase inhibitors  
Novel pyrrolidine compounds that are potent and selective inhibitors of PDE4, as well as methods of making the same, are disclosed. Use of the compounds in the treatment of inflammatory diseases...
6713472 Thiazine or pyrazine derivatives  
A compound which is a chymase inhibitor and which is represented by a formula [I] and salts thereof. In the formula [I], X is R 6 —(A 2 ) n —N, R 1 and R 2 are H, alkyl, cycloalkyl or aryl, R...
Matches 1 - 50 out of 389 1 2 3 4 5 6 7 8 >